Castle Creek Biosciences
Castle Creek Biosciences is a late‑stage biotechnology company developing autologous fibroblast‑based gene therapies for rare genetic skin disorders such as dystrophic epidermolysis bullosa. The firm conducts a registrational trial of its lead candidate D‑Fi and aims to create transformative, personalized treatments for patients with severe genetic diseases. It operates from Exton, Pennsylvania, and focuses on both ex vivo and in vivo approaches to deliver durable therapeutic outcomes.
Castle Creek Biosciences is profiled on the APIs.io network. Tagged areas include Biotechnology, Gene Therapy, Regenerative Medicine, Healthcare, and Biotech Company.
Castle Creek Biosciences’ developer surface includes documentation and 11 more developer resources.
Kin Score
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Documentation 1
Reference material describing how the API behaves
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 4
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API
Other 3
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.